Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study serves as a confirmation of safety, tolerance and efficacy of PICOPREP in clinical practice.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PICOPREP® |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sodium picosulphate | Drug | Sodium picosulphate (PICOPREP®) taken by participant prior to X-ray examination, endoscopy or surgery. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Documentation of use PICOPREP in everyday practice | Day 0 - 2 |
| Measure | Description | Time Frame |
|---|---|---|
| Participant satisfaction and compliance after bowel cleansing | Days 0-2 | |
| Participants with adverse events reported by frequency and severity | Days 1-2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients about to undergo X-ray examination, endoscopy or surgery.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clinical Development Support | Ferring Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Ostrava - Poruba | Czechia | ||||
| University Hospital |
Not provided
| ID | Term |
|---|---|
| C005701 | picosulfate sodium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Pilsen |
| Czechia |
| Iscare - Prague 7 | Prague | Czechia |